ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO1016

Association of Race/Ethnicity and Pre-ESKD Disease Duration with Subsequent Dialysis Mortality in US Veterans with ESKD

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Yan, Guofen, University of Virginia, Charlottesville, Virginia, United States
  • Nee, Robert, Walter Reed National Military Medical Center, Vienna, Virginia, United States
  • Norris, Keith C., UCLA, Marina Del Rey, California, United States
  • Greene, Tom, University of Utah, Salt Lake City, Utah, United States
  • Oliver, Mohammed Norman, Virginia Department of Health, Richmond, Virginia, United States
  • Yu, Wei, University of Virginia, Charlottesville, Virginia, United States
  • Cheung, Alfred K., University of Utah, Salt Lake City, Utah, United States
Background

The mortality rate of patients undergoing dialysis is exceptionally high. The role of disease duration before end-stage kidney disease (ESKD) on subsequent dialysis mortality is not clear due to lack of data on the accurate time of CKD onset. Using a national incident CKD cohort we recently constructed, we examined the association between disease duration prior to ESKD and dialysis mortality by race/ethnicity.

Methods

We first identified all subjects with new onset CKD (stage 3-5) in the U.S. Veteran Affairs database since 4/1/2002. CKD onset was determined by two eGFRs (based on CKD-EPI equation) <60 mL/min/1.73 m2 at >90 days apart. We then extracted the subset of patients who started dialysis with at least one year of follow-up until 5/1/2016. Disease duration was determined as time from the date of CKD onset to the date of first dialysis. Hazard ratios for death were examined for duration of <1 year, 1-3 years, and 3-5 years as compared to duration of ≥5 years for each race/ethnicity, adjusted for covariates including age at ESKD onset, gender, last eGFR prior to first dialysis, and major comorbid conditions such as diabetes, hypertension, and cardiovascular diseases.

Results

Of 28,129 incident dialysis patients included, 8,874 were Black, 1,892 Hispanic, and 17,363 White. The median duration from CKD onset to ESKD onset was 2.7 years for Blacks, 2.8 for Hispanics, and 3.3 for Whites. More than half of Blacks (55%) and Hispanics (53%) developed ESKD within 3 years of CKD onset, compared to 46% of Whites. After adjustments, shorter disease duration before ESKD was significantly associated with greater mortality on dialysis for Blacks, but not for Whites and Hispanics (Table). P value for testing the differential associations across three racial/ethnic groups was 0.003.

Conclusion

Our findings suggest the association of disease duration before ESKD and dialysis mortality differed by race/ethnicity, prompting the need to delineate the factors responsible for these differential associations.

Adjusted hazard ratios (HR) by race/ethnicity
 BlackHispanicWhite
Pre-ESKD duration (years)% patientsHR (95% CI)P value% patientsHR (95% CI)P value% patientsHR (95% CI)P value
<119.61.32 (1.19-1.46)<0.00120.31.05 (0.86-1.27)0.6415.71.01 (0.95-1.07)0.78
1-334.91.15 (1.04-1.25)0.00432.91.01 (0.85-1.19)0.9330.10.96 (0.92-1.01 )0.15
3-523.21.15 (1.04-1.26)0.00622.00.93 (0.77-1.11)0.4224.20.99 (0.94-1.04)0.58
≥522.31 24.81 30.0  

Funding

  • NIDDK Support